Osaic Holdings’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Osaic Holdings’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,000	Closed	-$1.81K	–	7630
2023 Q2	$1.81K	Hold	1,000	–	–	﹤0.01%	6704
2023 Q1	$1.32K	Hold	1,000	–	–	﹤0.01%	6868
2022 Q4	$1.69K	Buy	+1,000	New	+$1.27K	﹤0.01%	6791

Other funds holding PRDS

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Osaic Holdings's PRDS Position: Q3 2023 in Review

Osaic Holdings sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 1,000 shares — an estimated $1.81K sold.

Osaic Holdings first reported a position in PRDS in Q4 2022 and held it in 3 quarters. The position peaked at $1.81K in Q2 2023. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

Osaic Holdings reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Osaic Holdings sold 1,000 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $1.81K.
Osaic Holdings first reported a position in Pardes Biosciences, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
Osaic Holdings's Pardes Biosciences, Inc. Common Stock position peaked at $1.81K in Q2 2023.
1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on Osaic Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.